Fujita Health University · Faculty of Medicine / Graduate School of Medicine · 助教

Research keywordsmalignant mesothelioma・YAP1 signaling・YAP1/TAZ activation・TEAD inhibitor resistance・mTORC1 signaling・thoracic oncology・SmgGDS

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• BRAF V600E-mutant squamous cell carcinoma of the lung in patients with a history of papillary thyroid carcinoma: A three-case series.2026
• TEAD-Independent Cell Growth of Hippo-Inactive Mesothelioma Cells: Unveiling Resistance to TEAD Inhibitor K-975 through MYC Signaling Activation.2025
• It might be a dead end: immune checkpoint inhibitor therapy in EGFR-mutated NSCLC.2024
• Aberrant expression of NPPB through YAP1 and TAZ activation in mesothelioma with Hippo pathway gene alterations2023

• Official profile